Found: 2
Select item for more details and to access through your institution.
A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 9, p. 1892, doi. 10.1038/leu.2014.69
- By:
- Publication type:
- Article
RADIATION THERAPY AS A BRIDGING AND SALVAGE STRATEGY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA UNDERGOING BCMA‐TARGETED CAR T‐CELL THERAPY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 780, doi. 10.1002/hon.3165_628
- By:
- Publication type:
- Article